Replies to post #142 on Yubo International Biotech Ltd. (YBGJ)

[Potse]

December 8 Beijing ceremony.....

I noticed that Yubo added two more revolving slides to its homepage yesterday. Both slides have December 8 dates on them. Getting accurate/sensible translations from pictures/images is always difficult. But the first slide appears to have reference to Yubo's American listing, and the second slide refers to a Yubo biomedical application forum and the promotion of the VIV-CELL Experience Centers. My guess is this second slide means that Yubo will be hosting or participating in some type of a conference/forum where the biomedical applications of its stem cell technologies will be discussed.

I'm still holding my full position in YBGJ. If things go well, I am currently looking for a break over the $3.5 price before I try to reduce my position.

The company added a "media reports" section to its website last week following the December 8 Beijing ceremony/conference mentioned above. Below is the translated text of the news item that was circulated/distributed to 30+ news outlets in China/Asia following this ceremony. Yubo's American listing is mentioned at the end of this item. There were three pictures that accompanied this news item. The resolution/clarity of the first picture makes it hard to see, but I think the YBGJ stock symbol can be seen toward the right side of the presentation stage.......

http://yubogroup.com/details/info2-1.html

The global promotion ceremony of Feibo International Biomedical Application Experience Center was held in Beijing

On December 8, the global promotion ceremony of Feibo International Biomedical VIV-CELL Experience Center, which represents the current trend of biomedical applications, was held in Beijing.

With the continuous strengthening of R&D investment and technical strength in the cell biology industry, the number of cell therapy clinical research carried out in China has been increasing year by year, and there are more and more calls for the research and development, industrialization and clinical application of related products, especially market-based promotion service applications. High, especially after the outbreak of the new crown pneumonia epidemic in 2020, accelerating the development of biomedicine has become a global consensus, which also makes this conference extraordinary and attracts more attention.

Feather Platinum International Biomedical VIV-CELL Experience Center, based on unique endometrium stem cell application technology, mainly provides the experience and service of biomedical-level home stem cell preparation products. The service varieties and functions cover life, health, beauty, and anti-aging In all aspects, including stem cell precision skin care series, stem cell dual-sex personal care series, stem cell conditional culture supernatant inhalation, stem cell hair fixation essence, stem cell anti-aging intervention series, all series of products require cell energy detection and cell health management Under the program, it can be used with various methods such as introduction instrument, oxygen injection instrument, sonic instrument, atomizer, energy instrument and so on.

With the global promotion of the VIV-CELL Experience Center of Feibo International Biomedicine, it will surely lead and subvert the service model and customer experience of the traditional health care and beauty market, open up new economic models and engines for technological innovation to promote economic development, and serve the public Make due contributions to the cause of health and beauty.

The launch of Feibo International's Nasdaq listing in the United States was also carried out at the same time.